Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mexiletine and lacosamide crossover study of nerve excitability in healthy volunteers
NL-OMON48588Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Sep 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of fresolimumab and lacosamide in pain (3 arms), sponsored by Centre for Human Drug Research. Primary endpoint: Nerve excitability threshold endpoints. Started Sep 2019; status: completed.
02
Drugs
fresolimumablacosamide
03
Conditions
pain
Beyond the preview
Go deeper on NL-OMON48588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48588.